Deals, Partnering

Teva aims to add $2.4bn to respiratory franchise

Posted on 05 November 2010

Tags: ,

As usual, Teva Pharmaceutical Industries has big plans. It has stated that it wants to reach $31 billion in revenues by 2015. To do that, the Israeli drugmaker plans to grow not only in the generics sector--where it's already the biggest in the world--but in branded drugs. And it expects $2.4 billion of the new revenue to come from respiratory meds.

Read more on Teva's plans here (link no longer available)

Print Friendly, PDF & Email

Leave a Reply